Drug recall · November 27, 2013
Aldactone recall
Why: Marketed without an Approved NDA/ANDA: This recall is being initiated because of changes to the dissolution profile in distributed lots resulting from a manufacturing site change. There is currently no approved application supporting the alternate manufacturing site.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Distributed by G.D. Searle, Division of Pfizer Inc, NY, NY 10017, NDC 0025-1031-31
- Lots / codes
Lot #: V121573, Exp 05/17
- Quantity
- 31 bottles
- Company
- Pfizer Us Pharmaceutical Group, New York, NY
- Distribution
- US Nationwide
- Initiated
- September 4, 2013 · Voluntary: Firm initiated
- Classified
- November 20, 2013
- Reported
- November 27, 2013
- Ended
- April 13, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Spironolactone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.